Previously, it was described that SERPINA1 overexpression was also observed in cutaneous melanoma [70], pancreatic ductal adenocarcinoma [71], colorectal cancer [72], and non-small-cell lung cancer (NSCLC) [25]. This evidence concerns the gene SERPINA1 and colorectal cancer.